Orchid Enters Genotyping Deal for Autoimmune Diseases | GenomeWeb

NEW YORK, Sept. 25 - Orchid BioSciences has entered into a commercial SNP genotyping partnership with the Oklahoma Medical Research Foundation to study autoimmune diseases, especially lupus, the company said on Tuesday.

Terms of the deal call for Orchid to use its MegaSNPatron facility for an undisclosed fee to perform high throughput SNP scoring on samples provided by OMRF.

Further details of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.